The HHS Office of ... Nevertheless, the OIG stated that the risk of fraud and abuse presented by the proposed arrangement is sufficiently low under AKS for the OIG to issue a favorable advisory ...

The FDA needs to strengthen guardrails to ensure its accelerated approval pathway is used appropriately, the HHS Office of Inspector General (OIG) said. The agency should do two things ...